Table 1.
Characteristic | Value |
---|---|
Median age, y | 61 (52-75) |
Median prior therapies | 0 (0-2) |
No prior therapy | 27 (63%) |
Median bone marrow involvement | 55% (5%-100%) |
Adenopathy and/or splenomegaly | 5 (12%) |
Median IgM, mg/dL | 3840 (655-10500) |
IgM > 3000 mg/dL | 27 (63%) |
Hematocrit < 30% | 15 (35%) |
Platelets < 100 000/mm3 | 4 (9%) |